港股收評:恆生科技指數跌4.05%,內房、物管股齊跌,山東新華製藥逆勢飆漲逾53%
港股三大指數全天呈低開低走行情,市場整體情緒趨弱。恆生科技指數大幅收跌4.05%,恆指、國指分別跌2.2%和3.01%。南下資金逆勢淨流入86.53億港元,大市成交額為1587億港元。

盤面上,大型科技股齊挫,美團、百度跌近7%,阿里巴巴、京東、騰訊、小米皆有跌幅;內房股與物管股全天表現弱勢,餐飲股、汽車股、體育用品股、有色金屬股、家電股、軍工股等紛紛走低。另一方面,感染者居家中醫藥診療指引發布,中醫藥股全天強勢領漲,山東新華製藥飆升近54%,航空股、電影概念股、香港銀行股多數逆勢上漲,互聯網醫療股尾盤拉昇,平安好醫生由跌轉漲至1.3%。
具體來看:
大型科技股齊挫,美團、百度跌近7%,阿里巴巴、京東、騰訊、小米皆有跌幅。

汽車股跌幅居前,理想汽車跌超12%,小鵬汽車跌超11%,零跑汽車跌近8%,蔚來跌6.56%,吉利汽車跌4.15%。

物管股普跌,碧桂園服務、榮萬家跌超16%,時代鄰里跌超15%,正榮服務跌近14%,寶龍商業、融創服務跌超11%,合景悠活、新城悦服務跌超9%。

內房股表現低迷,新城發展跌超16%,龍湖集團跌超11%,,綠城中國跌9.46%,寶龍地產、旭輝控股集團跌超7%,合景泰富集團、融信中國、龍光集團跌超6%。

餐飲股集體下跌,奈雪的茶跌7.63%,九毛九跌6.12%,海底撈跌5.71%,百勝中國、呷哺呷哺跌超3%。

蘋果概念股普跌,舜宇光學科技跌超12%,丘鈦科技跌7.26%,富智康集團跌4.44%,瑞聲科技跌1%。

消息面上,丘鈦科技9日披露2022年11月主營產品銷售數據,當月攝像頭模組銷售合計3590.5萬件,同比減少23.5%;手機攝像頭模組銷售3484.2萬件,同比減少25.3%。舜宇光學科技11月,於光學零件分部,玻璃球面鏡片出貨量129.2萬件,同比下降61.5%;手機鏡頭出貨量9103.4萬件,同比下降26.4%;車載鏡頭出貨量740.5萬件,同比增長47.4%。
中藥板塊全天強勢,健倍苗苗漲超12%,白雲山漲8.47%,同仁堂國藥漲3.11%,神威藥業漲2.25%。

12月10日,國家中醫藥管理局正式發佈《新冠病毒感染者居家中醫藥干預指引》,對民眾居家服用藥物作出指導。在成人治療方案方面,指引提出,症見發熱、惡風寒、肌肉痠痛、咽乾咽痛、乏力、或鼻塞流涕、或咳嗽者,宜服用具有疏風解表功效的中成藥。
航空板塊表現活躍,中國南方航空股份、中國東方航空股份漲超4%,中國國航、國泰航空跟漲。

個股方面
山東新華製藥股份漲超53%。據新華製藥12月10日公眾號文,目前,隨着國內多地調整優化新冠防疫政策,全國進入疫情居家防控新時期,新冠病毒防治藥物的市場需求急劇增加。12月8日,國務院聯防聯控機制發佈了《新冠病毒感染者居家治療常用藥參考表》,為大家提供了健康參考。新華製藥生產的布洛芬、對乙酰氨基酚、阿司匹林、氯雷他定、西替利嗪等藥物均在目錄內。

南下資金淨流入86.53億港元,其中港股通(滬)淨流入42.5億港元,港股通(深)淨流入44.03億港元。

展望後市,中金認為,考慮到短期技術面處於超買區域、“三重壓力”在明顯改善後速度也可能減弱,市場若出現短暫休整甚至盤整,我們認為也可以理解,但這不會扭轉已經形成的修復趨勢,只不過更多的上漲空間有賴盈利進一步修復。同時近期國內政策力度有望進一步加大以回覆經濟增長動能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.